227 related articles for article (PubMed ID: 32484273)
1. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3-Triazoles: A Computational Docking Techniques.
Sadineni K; Reddy Basireddy S; Rao Allaka T; Yatam S; Bhoomandla S; Muvvala V; Babu Haridasyam S
Chem Biodivers; 2024 May; 21(5):e202400389. PubMed ID: 38457745
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
5. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
6. Click chemistry based regioselective one-pot synthesis of coumarin-3-yl-methyl-1,2,3-triazolyl-1,2,4-triazol-3(4H)-ones as newer potent antitubercular agents.
Somagond SM; Kamble RR; Bayannavar PK; Shaikh SKJ; Joshi SD; Kumbar VM; Nesaragi AR; Kariduraganavar MY
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900013. PubMed ID: 31397503
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.
Alegaon SG; Alagawadi KR; Dadwe DH
Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205
[TBL] [Abstract][Full Text] [Related]
9. Design, Facile Synthesis and Characterization of Dichloro Substituted Chalcones and Dihydropyrazole Derivatives for Their Antifungal, Antitubercular and Antiproliferative Activities.
Shaik AB; Bhandare RR; Nissankararao S; Edis Z; Tangirala NR; Shahanaaz S; Rahman MM
Molecules; 2020 Jul; 25(14):. PubMed ID: 32668655
[TBL] [Abstract][Full Text] [Related]
10. Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents.
Ahmad I; Thakur JP; Chanda D; Saikia D; Khan F; Dixit S; Kumar A; Konwar R; Negi AS; Gupta A
Bioorg Med Chem Lett; 2013 Mar; 23(5):1322-5. PubMed ID: 23369537
[TBL] [Abstract][Full Text] [Related]
11. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Screening and Docking Analysis of Hispolon Pyrazoles and Isoxazoles as Potential Antitubercular Agents.
Balaji NV; HariBabu B; Rao VU; Subbaraju GV; Nagasree KP; Kumar MMK
Curr Top Med Chem; 2019; 19(9):662-682. PubMed ID: 30834836
[TBL] [Abstract][Full Text] [Related]
13. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.
Kasetti AB; Singhvi I; Nagasuri R; Bhandare RR; Shaik AB
Molecules; 2021 May; 26(10):. PubMed ID: 34064806
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, In silico and Biological Studies of Thiazolyl-2h-chromen-2-one Derivatives as Potent Antitubercular Agents.
Jadhav BS; Yamgar RS; Kenny RS; Mali SN; Chaudhari HK; Mandewale MC
Curr Comput Aided Drug Des; 2020; 16(5):511-522. PubMed ID: 31438831
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents.
Gaikwad NB; Nirmale K; Sahoo SK; Ahmad MN; Kaul G; Shukla M; Nanduri S; Das Gupta A; Chopra S; Yaddanapudi MV
Arch Pharm (Weinheim); 2021 May; 354(5):e2000349. PubMed ID: 33351199
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents.
Küçükgüzel SG; Rollas S
Farmaco; 2002 Jul; 57(7):583-7. PubMed ID: 12164219
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
Pathak RB; Chovatia PT; Parekh HH
Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129
[TBL] [Abstract][Full Text] [Related]
19. Novel Furan Coupled Quinoline Diamide Hybrid Scaffolds as Potent Antitubercular Agents: Design, Synthesis and Molecular Modelling.
Rajpurohit A; Satyanarayan ND; Pathak L; Ayyanar S; Rishinaradamangalam CR; Shoorapani P
Med Chem; 2020; 16(4):507-516. PubMed ID: 31483232
[TBL] [Abstract][Full Text] [Related]
20. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
